Expert Review of Neurotherapeutics

Papers
(The TQCC of Expert Review of Neurotherapeutics is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Metformin as a potential therapeutic for neurological disease: mobilizing AMPK to repair the nervous system57
Istradefylline – a first generation adenosine A2A antagonist for the treatment of Parkinson’s disease55
Diagnosing and managing post-stroke aphasia40
Sex differences in schizophrenia relevant to clinical care36
Post Intensive Care Syndrome (PICS): an overview of the definition, etiology, risk factors, and possible counseling and treatment strategies33
Ganaxolone treatment for epilepsy patients: from pharmacology to place in therapy30
Focal cortical dysplasia: an update on diagnosis and treatment29
A critical review of the capsaicin 8% patch for the treatment of neuropathic pain associated with diabetic peripheral neuropathy of the feet in adults27
Nutrition-based interventions for mood disorders27
Role of environmental factors in multiple sclerosis27
Pain in cervical dystonia: mechanisms, assessment and treatment26
What is the potential of paramagnetic rim lesions as diagnostic indicators in multiple sclerosis?26
Clinical development of valbenazine for tics associated with Tourette syndrome25
Nutraceuticals-based therapeutic approach: recent advances to combat pathogenesis of Alzheimer’s disease24
Sensory stimulation programs in dementia: a systematic review of methods and effectiveness22
Redefining the strategy for the use of COMT inhibitors in Parkinson’s disease: the role of opicapone22
Robot Assisted Ankle Neuro-Rehabilitation: State of the art and Future Challenges21
Non-motor complications in late stage Parkinson’s disease: recognition, management and unmet needs21
Updated review of therapeutic strategies for Charcot-Marie-Tooth disease and related neuropathies20
An updated brief overview on post-traumatic headache and a systematic review of the non-pharmacological interventions for its management20
Motor imagery and gait control in Parkinson’s disease: techniques and new perspectives in neurorehabilitation20
The effect of physical activity with and without cognitive demand on the improvement of executive functions and behavioral symptoms in children with ADHD19
Speech and language therapy in primary progressive aphasia: a critical review of current practice19
Updated perspectives on the clinical significance of negative symptoms in patients with schizophrenia19
Assessment of clinical outcomes of medicinal cannabis therapy for depression: analysis from the UK Medical Cannabis Registry19
Reading mind from the eyes in individuals with attention deficit-hyperactivity disorder (ADHD): A meta-analysis19
Current perspectives on the diagnosis and management of fatigue in multiple sclerosis19
Ketogenic diet in pediatric seizures: a randomized controlled trial review and meta-analysis18
Acute ischemic stroke management: concepts and controversies.A narrative review18
Current and emerging treatment modalities for spinocerebellar ataxias18
Adaptive, personalized closed-loop therapy for Parkinson’s disease: biochemical, neurophysiological, and wearable sensing systems17
Status epilepticus in pregnancy: a literature review and a protocol proposal17
Assessment, goal setting, and botulinum neurotoxin a therapy in the management of post-stroke spastic movement disorder: updated perspectives on best practice17
Current perspectives on galvanic vestibular stimulation in the treatment of Parkinson’s disease16
An evaluation of the combination of sodium phenylbutyrate and taurursodiol for the treatment of amyotrophic lateral sclerosis16
Considering patient age when treating multiple sclerosis across the adult lifespan16
Current challenges in the pathophysiology, diagnosis, and treatment of paroxysmal movement disorders16
Recent advancements in tension-type headache: a narrative review16
The efficacy of executive function interventions in children with autism spectrum disorder: a systematic review and meta-analysis16
Sydenham’s chorea: from pathophysiology to therapeutics16
Considering hearing loss as a modifiable risk factor for dementia15
Real world considerations for newly approved CGRP receptor antagonists in migraine care14
Vitamin D supplementation in multiple sclerosis: an expert opinion based on the review of current evidence14
A systematic review of longitudinal studies investigating the impact of cannabis use in patients with psychotic disorders14
Vigabatrin-related adverse events for the treatment of epileptic spasms: systematic review and meta-analysis14
The impact of COVID-19 on palliative care for people with Parkinson’s and response to future pandemics14
Personalized treatment interventions: nonpharmacological and natural treatment strategies in Alzheimer’s disease14
The role of a potential biomarker in patients with migraine: review and new insights14
Outcomes measures in idiopathic intracranial hypertension14
Optimal outcome measures for assessing exercise and rehabilitation approaches in chemotherapy-induced peripheral-neurotoxicity: Systematic review and consensus expert opinion13
Clinical outcome data of chronic pain patients treated with cannabis-based oils and dried flower from the UK Medical Cannabis Registry13
Beyond chronic migraine: a systematic review and expert opinion on the off-label use of botulinum neurotoxin type-A in other primary headache disorders13
Nutraceutical induction and mimicry of heme oxygenase activity as a strategy for controlling excitotoxicity in brain trauma and ischemic stroke: focus on oxidative stress12
Pharmacological Treatment of Generalised Anxiety Disorder: Current Practice and Future Directions12
An update on clinical insight, cognitive insight, and introspective accuracy in schizophrenia-spectrum disorders: symptoms, cognition, and treatment12
Evaluating and managing severe headache in the emergency department12
A critical review of incobotulinumtoxinA in the treatment of chronic sialorrhea in pediatric patients12
Current perspectives on the benefits, risks, and limitations of noninvasive brain stimulation (NIBS) for post-stroke dysphagia12
Diagnostic and therapeutic approach to drug-resistant juvenile myoclonic epilepsy12
Assessment of clinical outcomes in patients with post-traumatic stress disorder: analysis from the UK Medical Cannabis Registry11
A critical evaluation of midazolam nasal spray for the treatment of patients with seizure clusters11
The second phase of brain trauma can be controlled by nutraceuticals that suppress DAMP-mediated microglial activation11
Present and future of subthalamotomy in the management of Parkinson´s disease: a systematic review11
Adjunctive cenobamate for the treatment of focal onset seizures in adults with epilepsy: a critical review11
Characteristics of a population-based multiple sclerosis cohort treated with disease-modifying drugs in a universal healthcare setting11
The APOE ε4 variant and hippocampal atrophy in Alzheimer’s disease and Lewy body dementia: a systematic review of magnetic resonance imaging studies and therapeutic relevance11
A systematic review with expert opinion on the role of gepants for the preventive and abortive treatment of migraine11
Updated review on the link between cortical spreading depression and headache disorders11
The effect of transcranial magnetic stimulation on the recovery of attention and memory impairment following stroke: a systematic review and meta-analysis10
A critical evaluation of fenfluramine hydrochloride for the treatment of Dravet syndrome10
Suicidality and antiepileptic drugs in people with epilepsy: an update10
Developments in the assessment of non-motor disease progression in amyotrophic lateral sclerosis10
Safety and tolerability of nabiximols oromucosal spray: a review of more than 15 years” accumulated evidence from clinical trials10
Oral Edaravone – Introducing a Flexible Treatment Option for Amyotrophic Lateral Sclerosis10
Vitamin D in the development and progression of alzheimer’s disease: implications for clinical management10
Use of cenobamate for the treatment of focal epilepsy: an Italian expert opinion paper10
Tele-healthcare in migraine medicine: from diagnosis to monitoring treatment outcomes10
Chronic active lesions: a new MRI biomarker to monitor treatment effect in multiple sclerosis?10
Understanding and managing the impact of the Covid-19 pandemic and lockdown on patients with multiple sclerosis10
Treatment for cognitive and neuropsychiatric non-motor symptoms in Parkinson’s disease: current evidence and future perspectives10
Tumefactive demyelination: updated perspectives on diagnosis and management10
Pediatric multiple sclerosis: developments in timely diagnosis and prognostication10
Beyond McDonald: updated perspectives on MRI diagnosis of multiple sclerosis9
Cancer-related cognitive impairment: current perspectives on the management of cognitive changes following cancer treatment9
Safety and tolerability of nabiximols oromucosal spray: a review of real-world experience in observational studies, registries, and case reports9
Efficacy and safety of greater occipital nerve block for the treatment of cervicogenic headache: a systematic review9
The changing landscape of neuroimaging in frontotemporal lobar degeneration: from group-level observations to single-subject data interpretation9
Updated perspectives on awake neurosurgery with cognitive and emotional assessment for patients with low-grade gliomas9
Pharmacotherapy of schizophrenia: immunological aspects and potential role of immunotherapy9
Central vestibular dysfunction: don’t forget vestibular rehabilitation9
Optimizing levodopa therapy, when and how? Perspectives on the importance of delivery and the potential for an early combination approach9
Outcome measures and biomarkers in chronic inflammatory demyelinating polyradiculoneuropathy: from research to clinical practice9
Smell tests to distinguish Parkinson’s disease from other neurological disorders: a systematic review and meta-analysis9
The benefits and risks of escalation versus early highly effective treatment in patients with multiple sclerosis9
A review of a diazepam nasal spray for the treatment of acute seizure clusters and prolonged seizures9
Retinal optical coherence tomography and magnetic resonance imaging in neuromyelitis optica spectrum disorders and MOG-antibody associated disorders: an updated review9
A critical review of apomorphine hydrochloride sublingual film for the treatment of Parkinson’s disease ‘OFF’ episodes9
Lasmiditan: an additional therapeutic option for the acute treatment of migraine8
Pathogenesis and Management of Acute Necrotizing Encephalopathy8
Comparing the effects of medical cannabis for chronic pain patients with and without co-morbid anxiety: A cohort study8
Why lithium should be used in patients with bipolar disorder? A scoping review and an expert opinion paper8
An updated review on the role of prescribed exercise in the management of Amyotrophic lateral sclerosis8
The efficacy of rehabilitation in people with Guillain-Barrè syndrome: a systematic review of randomized controlled trials8
Non-pharmacological treatments for pediatric refractory epilepsies8
Cognitive function in diabetic persons with peripheral neuropathy: a systematic review and meta-analysis8
Aripiprazole for the treatment of Tourette syndrome8
Deutetrabenazine for treatment of involuntary movements in patients with tardive dyskinesia8
Meniere disease subtyping: the direction of diagnosis and treatment in the future8
0.042111873626709